Proscia Launches Fifth Generation Concentriq Platform

Proscia introduced the Fifth Generation of its Concentriq platform, built on a new AI-native architecture. The platform delivers clinically and scientifically grounded intelligence to support pathologists and scientists in drug discovery, development, and case review. Proscia serves diagnostic labs managing 12 million patient cases annually and 16 of the top 20 pharmaceutical companies.